Metraipolis › archive › dc_43b26dc9182c

The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42357270
DOI
10.3390/pharmaceutics18060654
License (as archived)
solo-consultazione
Archived
2026-11-01T06:05:21.720Z
SHA-256 of the archived text
15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c
Stable URL of this page
https://metraipolis.com/documento/dc_43b26dc9182c

How to cite

The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270 — Europe PMC (en), https://europepmc.org/article/MED/42357270 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43b26dc9182c (Metraipolis archive dc_43b26dc9182c, sha256 15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c)
BibTeX
@misc{dc43b26dc9182c,
  title = {The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42357270},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43b26dc9182c; sha256 15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357270. Agents can read the archived copy with the MCP tool read_document.